David A. Jenkins - 23 Mar 2023 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Signature
/s/ David Jenkins
Issuer symbol
VTAK
Transactions as of
23 Mar 2023
Net transactions value
$0
Form type
4
Filing time
27 Mar 2023, 17:18:44 UTC
Previous filing
11 Jan 2023
Next filing
18 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMED Common Stock Conversion of derivative security $0 +277,597 $0.000000 277,597 23 Mar 2023 Direct F1
transaction RMED Common Stock Conversion of derivative security $0 +709,703 $0.000000 709,703 23 Mar 2023 See footnote F1, F2
transaction RMED Common Stock Conversion of derivative security $0 +2,264 $0.000000 2,264 23 Mar 2023 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -278 -11% $0.000000 2,292 23 Mar 2023 Common Stock 2,292,339 $0.000000 Direct F4, F5
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -710 -11% $0.000000 5,861 23 Mar 2023 Common Stock 5,860,540 $0.000000 See footnote F2, F4, F5
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -2 -11% $0.000000 19 23 Mar 2023 Common Stock 18,691 $0.000000 See footnote F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2 Shares held by a partnership of which the reporting person is the managing member of the managing partner.
F3 Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.
F4 Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
F5 Series X Convertible Preferred Stock has no expiration date.